Drug Type Gene editing |
Synonyms ABO 201 (Arbor Biotechnologies), ABO201 (Arbor Biotechnologies) |
Target |
Mechanism C9orf72 gene inhibitors(C9orf72-SMCR8 complex subunit gene inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Discovery | US | Arbor Biotechnologies, Inc.Startup | 27 Feb 2024 |
Central Nervous System Diseases | Discovery | US | Arbor Biotechnologies, Inc.Startup | 06 Jul 2023 |